Global Research PartnershipsCreate free account
Industry Collaboration Index

Industry Collaboration Index 2026 · University profile

Catholic University of Korea

South Korea · Asia-Pacific · Silver

#324World rank of 1,038
61.3ICI scoreout of 100
#10National rank, of 28 in South Korea
#91Regional rank, of 343 in Asia-Pacific
865Verified industry works, 2021 to 2025
223Company groups worked with (88 on two or more works)

Catholic University of Korea is ranked #324 of 1,038, with Silver standing. Its strongest pillar is durability (97): 38 of its company groups are sustained partners (five or more joint works in three or more of the five years). It is held back most by breadth (18): partners concentrated in a few research fields.

Research Collaboration Index 2026: #863 of 1,195 · View the RCI profile →

Why this position

Four pillars, as percentiles

Co-creation30% of the score
62

How often it co-authors with companies, compared with what its own mix of research fields would predict; size makes no difference. 865 verified works against about 763 expected for its fields (1.13 times the expected rate).

Durability20% of the score
97

How much of its industry work sits in sustained partnerships with the same company group. 38 sustained partnerships: five or more joint works in three or more of the five years.

Scale30% of the score
65

The size of its industry network: company groups on two or more works, sustained partnerships, and its place in the worldwide network of universities and companies. 88 company groups on two or more joint works; 38 sustained partnerships.

Breadth20% of the score
18

How varied its partners are, judged by each company's main research field. Measured across the main research fields of all the company groups it worked with.

Each pillar is a percentile among the 1,038 ranked universities: a value of 80 means a higher value than about 80 in every 100 of them. The ICI score (61.3) is the weighted average of the four percentiles. Rank 324 of 1,038 overall; 10 of 28 in South Korea; 91 of 343 in Asia-Pacific. Standing bands: Platinum for ranks 1 to 100, Gold 101 to 300, Silver 301 to 600. How the index is built →

In numbers

The evidence behind the position

5.4%of its 15,890 research works in 2021 to 2025 were co-authored with a verified company
1.13Industry co-authorship rate: 1.13 times what its mix of research fields would predict (865 verified works; about 763 expected)
38sustained partnerships: the same company group on five or more joint works in three or more of the five years

In South Korea

10 of 28 ranked universities in South Korea

  1. #8 Hanyang University world #272, score 64.3
  2. #9 Ulsan College world #285, score 63.4
  3. #10 Catholic University of Korea world #324, score 61.3
  4. #11 Pusan National University world #353, score 59.5
  5. #12 Chungnam National University world #408, score 56.4

All ranked universities →   Asia-Pacific: 91 of 343 →

Where it works with industry

Sector strengths

Verified industry works by sector, with its position in each sector ranking. A university is ranked in a sector once it has at least 20 verified works there; sectors with fewer than 50 eligible universities are provisional.

Strongest sector positions

#117 of 638Pharmaceuticals and Therapeutics283 verified works in the sector
#159 of 323Medical Technology and Digital Health40 verified works in the sector
Pharmaceuticals and Therapeutics
283#117 of 638
Medical Technology and Digital Health
40#159 of 323
Biotechnology and Advanced Therapies
32.5#111 of 220
Artificial Intelligence
8under 20 works
Advanced Manufacturing and Industry 4.0
7under 20 works
Clean Energy Transition
2under 20 works
Climate, Environment and Sustainability
2under 20 works
Software, Cloud and Data
2under 20 works
Agriculture and Food Technology
1under 20 works
Next-Generation Communications
1under 20 works
Not in any of the 21 sectors
485counted in the overall index

380 of its 865 verified industry works fall within the 21 sectors. The rest have research topics that belong to no industry sector (basic science, for example) or are consortium papers with 100 or more authors, which the sector indices leave out; all of them count fully in the overall index.

Who it works with

Company partners, 2021 to 2025

Catholic University of Korea co-authored verified work with 223 company groups, consortium papers aside: 88 of them on two or more works, and 38 as sustained partners.

The largest 12 of its 223 company groups, by joint works

Company groupBased inCompany's main research fieldJoint worksYears with a joint work
SamsungSouth KoreaEngineering1565 of 5
AstraZenecaUnited KingdomMedicine575 of 5
NeurophetSouth KoreaMedicine505 of 5
Hanmi PharmaceuticalSouth KoreaMedicine305 of 5
Siemens HealthineersGermanyMedicine29.55 of 5
PfizerUnited StatesMedicine285 of 5
Johnson & JohnsonUnited StatesMedicine245 of 5
GlaxoSmithKlineUnited KingdomMedicine235 of 5
RegeneronUnited StatesMedicine225 of 5
NovartisSwitzerlandMedicine205 of 5
SanofiFranceMedicine195 of 5
Daiichi SankyoJapanMedicine175 of 5

A company group brings together a company's subsidiaries and research labs under one name. A work counts half when its only company author also holds a post at this university. Consortium papers with 100 or more authors are left out of this table.

Examples of its work with industry

Most-cited verified joint works

Over time

Verified industry works by year

126.52021
1542022
2002023
1962024
188.52025

2025 is not yet complete: papers published late in the year are still being added to the open record, and coverage may not be equally complete for every university, so compare years with care. A work counts half when its only company author also holds a post at the university, so some totals end in .5.

Clinical trials (reported, not scored)

6 industry-partnered clinical trials

Trials starting 2021 to 2025 in ClinicalTrials.gov in which a company and this university are the sponsor and a collaborator. Names are matched exactly, so a trial registered only under an affiliated hospital's own name is not counted here, and the count can be well below the university's real trial activity. Trials do not enter the score.

Examples:

  • NCT07319377 Evaluation of Safety and Efficacy of a Digital Therapeutic Device to Improve Strength in Sarcopenia (Sarc-DTx) with Exosystems, 2025
  • NCT07091773 A Clinical Trial to Evaluate the Safety and Effectiveness of OLIZ, a Photobiomodulation Medical Device for Surgical Site Pain Relief in Patients After Total Knee Arthroplasty with LTBIO Co., Ltd., 2025
  • NCT07513415 A Comparative Study on the Safety and Efficacy of the Intra-Articular Injectable Filler ALLOHEAL in Patients With Knee Osteoarthritis with Endovision Co., Ltd., 2025
  • NCT06367998 Effect of Pregabalin on Shoulder Pain in Patients With Central Sensitization After Arthroscopic Rotator Cuff Repair with Viatris Korea, 2024
  • NCT06329141 A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients with Glaceum, 2024
  • NCT04718649 Effectiveness and Safety of Celecoxib (Celebrex 200 mg) Combined With Joins in the Treatment of Degenerative Knee Osteoarthritis: a Randomized Controlled Trial with SK Chemicals Co., Ltd., 2021

Evidence checked

1,181 verified company links

Each counted link (one work, this university and one company) was confirmed against the affiliation text its author wrote; 432 of 1,613 candidate links were set aside.

Why links were set aside
  • 206 company name not written in the author's affiliation
  • 136 part of a university or public institute's own unit
  • 59 ordinary-word name without a company suffix
  • 6 a place or common word that failed its stricter rule
  • 5 part of a street or district address
  • 4 excluded after hand audit: A healthcare provider and insurer
  • 16 for other reasons: smaller hand-audit findings, and links the current open record no longer supports

If a partner is missing or should not be here, send the evidence; corrections are free and reviewed against the public record.

For your communications

Badges you can use

Silver standing badge

Use the badge with a link to this page.

GRP Partnership Intelligence Platform

Where Catholic University of Korea's collaboration could go next

This profile is free and public, and it stays that way. Beyond it, the GRP Partnership Intelligence Platform, a partner service arranged with each university, sets your record in both GRP indices beside the peers you choose: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. It opens to partner universities on Monday 19 October 2026: enquire, and the GRP team will confirm availability and pricing for your university.

Request first access →  See what is inside →

The platform cannot move any university's position, band or score.

The other GRP index

Research Collaboration Index

In the Research Collaboration Index 2026, Catholic University of Korea ranks #863 of 1,195. It measures the whole research network, not only industry.

View the RCI profile →

Something wrong? Every figure comes from the public record and can be checked. If a partner is missing or should not be there, tell us and we will review it with the evidence. The 2027 edition will be calculated with the same published methodology. The window for universities to submit data for it is open now: submit data for the 2027 edition. The index is free, public and independent. No commercial relationship with any university or company changes any position, and no one can pay to be included, excluded or moved.